Nektar Therapeutics
NKTR
#4927
Rank
NZ$3.55 B
Marketcap
NZ$104.06
Share price
-2.70%
Change (1 day)
2.11%
Change (1 year)

Nektar Therapeutics (NKTR) - Net assets

Net assets on the balance sheet as of June 2026 : NZ$1.59 Billion

According to Nektar Therapeutics 's latest financial reports the company has NZ$1.59 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Nektar Therapeutics - Net assets on balance sheet (from 2001 to 2026)

Net assets by year

Year Net assets Change
2025-12-31$NZ$0.15 B44.03%
2024-12-31$NZ$0.10 B-48.01%
2023-12-31$NZ$0.20 B-64.13%
2022-12-31$NZ$0.57 B-41.95%
2021-12-31$NZ$0.99 B-33.37%
2020-12-31$NZ$1.49 B-28.45%
2019-12-31$NZ$2.08 B-18.5%
2018-12-31$NZ$2.56 B1970.57%
2017-12-31$NZ$0.12 B-2.79%
2016-12-31$NZ$0.12 B1254.37%
2015-12-31$NZ$9.39 M-79.74%
2014-12-31$NZ$46.37 M-142.39%
2013-12-31$-NZ$0.11 Billion-291.41%
2012-12-31$NZ$57.15 M-77.45%
2011-12-31$NZ$0.25 B115.68%
2010-12-31$NZ$0.11 B-16.62%
2009-12-31$NZ$0.14 B-56.99%
2008-12-31$NZ$0.32 B17.05%
2007-12-31$NZ$0.27 B-13.14%
2006-12-31$NZ$0.32 B-32.59%
2005-12-31$NZ$0.47 B-27%
2004-12-31$NZ$0.65 B159.3%
2003-12-31$NZ$0.25 B-36.07%
2002-12-31$NZ$0.39 B-39.31%
2001-12-31$NZ$0.65 B

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Johnson & Johnson
JNJ
NZ$150.45 B 9,308.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$151.38 B 9,366.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$20.69 B 1,194.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
NZ$10.94 B 584.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$74.34 B 4,548.77%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
NZ$89.19 B 5,477.33%๐Ÿ‡ฌ๐Ÿ‡ง UK
Richardson Electronics
RELL
NZ$0.28 B-81.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Alkermes
ALKS
NZ$3.10 B 93.94%๐Ÿ‡ฎ๐Ÿ‡ช Ireland